Fumaric Acid

Fumaric Acid

SCHEMBL6576532

CN(CCO)CCCC(Oc1cc(Cl)ccc1Cl)c1ccccc1.O=C(O)/C=C/C(=O)O

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 1/20 0.43
KMT2A known ✓ Q03164 1/20 0.43
SLC6A4 known ✓ P31645 4/20 0.42
SLC6A2 known ✓ P23975 3/20 0.42
KCNH2 known ✓ Q12809 1/20 0.39
NOS2 P35228 7/20 0.66
SLC6A9 P48067 5/20 0.47
CYP2D6 P10635 3/20 0.42
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6576541 1.00 NOS2 (0.66) NOS2SLC6A9MEN1KMT2ASLC6A4
SCHEMBL6577564 0.93 NOS2 (0.59) NOS2SLC6A9SLC6A4CYP2D6SLC6A2
SCHEMBL6576536 0.85 NOS2 (0.56) NOS2SLC6A9MEN1KMT2ASLC6A4
Fumaric Acid SCHEMBL6576539 0.81 NOS2 (0.70) NOS2MEN1KMT2ASLC6A4CYP2D6
Fumaric Acid SCHEMBL6491175 0.79 NOS2 (1.00) NOS2MEN1KMT2ASLC6A4CYP2D6
Fumaric Acid SCHEMBL6491990 0.79 NOS2 (1.00) NOS2MEN1KMT2ASLC6A4CYP2D6
Fumaric Acid SCHEMBL6579315 0.75 NOS2 (0.61) NOS2MEN1KMT2ASLC6A4CYP2D6
Fumaric Acid SCHEMBL6579320 0.75 NOS2 (0.61) NOS2MEN1KMT2ASLC6A4CYP2D6
Fumaric Acid SCHEMBL7316884 0.74 SLC6A9 (0.65) NOS2SLC6A9MEN1KMT2AKDM4E
Maleic Acid SCHEMBL7316880 0.74 SLC6A9 (0.65) NOS2SLC6A9MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6743939-B2 NITRIC OXIDE SYNTHASE INHIBITORS; SUCH AS 4-CHLORO-2-(((1)-4-(METHYLAMINO)-1-PHENYLBUTYL)OXY)BENZONITRILE ASTRAZENECA AB (SE) 2004-06-01 US disclosed
EP-1263714-B1 NOVEL PHENYLHETEROALKYLAMINE DERIVATIVES ASTRAZENECA AB (SE) 2004-04-28 EP disclosed
US-20030105161-A1 Novel phenylheteroalkylamine derivatives ASTRAZENECA AB (SE) 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105161-A1 Novel phenylheteroalkylamine derivatives NOS1, CYP1A1, NOS2 MEN1 4817/4885KMT2A 2767/4885SLC6A4 2202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.